AMRZ
$56.22-0.13 (-0.23%)
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America. It operates through two segments, Building Materials and Building Envelope. The Building Materials...
Recent News
Amrize Ltd (AMRZ) Launches New EVERtect High-Performance Concrete Product Line
Amrize Ltd (NYSE:AMRZ) is one of the Best Young Stocks To Buy and Hold For 20 Year. On March 3, Amrize Ltd (NYSE:AMRZ) announced the launch of its new EVERtect high-performance concrete product line. The announcement came at the CONEXPO-CON/AGG trade show in Las Vegas. Management noted that the new product line rebrands and standardizes […]
JPMorgan Raises PT on Amrize (AMRZ), Keeps a Buy Rating
Amrize Ltd (NYSE:AMRZ) is one of the Best Cement Stocks to Buy For the Long Term. On March 5, JPMorgan raised the firm’s price target on Amrize Ltd (NYSE:AMRZ) from $60 to $70, while keeping an Overweight rating on the shares. The rating follows Amrize’s fiscal Q4 2025 earnings reported on February 17. The company […]
A Look At Amrize (SWX:AMRZ) Valuation After Recent Share Price Momentum
Event context and recent share performance Amrize (SWX:AMRZ) has caught investor attention after recent trading left the stock with a 1 day return of 1.38%, a 7 day return showing a 2.30% decline, and a month return of 16.74%. See our latest analysis for Amrize. The recent 30 day share price return of 16.74% and 90 day share price return of 15.27%, on a CHF48.46 share price, point to building momentum over the shorter term. In contrast, the 8.90% year to date share price return suggests a...
Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating
Amrize Ltd (NYSE:AMRZ) is among the 11 Newly-Listed NYSE Stocks to Buy Now. On February 19, 2026, Oppenheimer increased its price target on Amrize Ltd (NYSE:AMRZ) to $70 from $64 and maintained an Outperform rating. The firm noted the shares moved higher after the company reported Q4 2025 EBITDA of $779M and issued 2026 revenue […]
Amrize Ltd (AMRZ) Q4 2025 Earnings Call Highlights: Strategic Moves and Financial Resilience
Amrize Ltd (AMRZ) reports steady revenue growth, strategic acquisitions, and robust cash flow amidst market challenges.